599 related articles for article (PubMed ID: 19067404)
1. Update on prevention of folic acid-preventable spina bifida and anencephaly.
Bell KN; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):102-7. PubMed ID: 19067404
[TBL] [Abstract][Full Text] [Related]
2. Tracking the prevention of folic acid-preventable spina bifida and anencephaly.
Bell KN; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2006 Sep; 76(9):654-7. PubMed ID: 17001686
[TBL] [Abstract][Full Text] [Related]
3. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
[TBL] [Abstract][Full Text] [Related]
4. 2012 Update on global prevention of folic acid-preventable spina bifida and anencephaly.
Youngblood ME; Williamson R; Bell KN; Johnson Q; Kancherla V; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):658-63. PubMed ID: 24000219
[TBL] [Abstract][Full Text] [Related]
5. Countries with an immediate potential for primary prevention of spina bifida and anencephaly: Mandatory fortification of wheat flour with folic acid.
Kancherla V
Birth Defects Res; 2018 Jul; 110(11):956-965. PubMed ID: 29532629
[TBL] [Abstract][Full Text] [Related]
6. A 2017 global update on folic acid-preventable spina bifida and anencephaly.
Kancherla V; Wagh K; Johnson Q; Oakley GP
Birth Defects Res; 2018 Aug; 110(14):1139-1147. PubMed ID: 30070772
[TBL] [Abstract][Full Text] [Related]
7. A 2015 global update on folic acid-preventable spina bifida and anencephaly.
Arth A; Kancherla V; Pachón H; Zimmerman S; Johnson Q; Oakley GP
Birth Defects Res A Clin Mol Teratol; 2016 Jul; 106(7):520-9. PubMed ID: 27418029
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
[TBL] [Abstract][Full Text] [Related]
9. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology.
Oakley GP
Ann Epidemiol; 2009 Apr; 19(4):226-30. PubMed ID: 19344858
[TBL] [Abstract][Full Text] [Related]
10. Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand.
Oakley GP; Weber MB; Bell KN; Colditz P
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):838-41. PubMed ID: 15390316
[TBL] [Abstract][Full Text] [Related]
11. A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects.
Kancherla V; Wagh K; Priyadarshini P; Pachón H; Oakley GP
Birth Defects Res; 2022 Dec; 114(20):1392-1403. PubMed ID: 36345648
[TBL] [Abstract][Full Text] [Related]
12. A 2019 global update on folic acid-preventable spina bifida and anencephaly.
Kancherla V; Wagh K; Pachón H; Oakley GP
Birth Defects Res; 2021 Jan; 113(1):77-89. PubMed ID: 33124747
[TBL] [Abstract][Full Text] [Related]
13. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia.
Dixon M; Kancherla V; Magana T; Mulugeta A; Oakley GP
Birth Defects Res; 2019 Nov; 111(19):1513-1519. PubMed ID: 31424635
[TBL] [Abstract][Full Text] [Related]
14. When will we eliminate folic acid-preventable spina bifida?
Oakley GP
Epidemiology; 2007 May; 18(3):367-8. PubMed ID: 17435446
[TBL] [Abstract][Full Text] [Related]
15. Preventable spina bifida and anencephaly in Europe.
Obeid R; Pietrzik K; Oakley GP; Kancherla V; Holzgreve W; Wieser S
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):763-71. PubMed ID: 26178749
[TBL] [Abstract][Full Text] [Related]
16. [Effects of wheat flour fortification with folic acid on the prevalence of neural tube defects in Chile].
Nazer H J; Cifuentes O L
Rev Med Chil; 2013 Jun; 141(6):751-7. PubMed ID: 24121578
[TBL] [Abstract][Full Text] [Related]
17. Reductions in child mortality by preventing spina bifida and anencephaly: Implications in achieving Target 3.2 of the Sustainable Development Goals in developing countries.
Kancherla V; Redpath B; Oakley GP
Birth Defects Res; 2019 Aug; 111(14):958-966. PubMed ID: 30070775
[TBL] [Abstract][Full Text] [Related]
18. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a folic acid fortification program in Chile.
Llanos A; Hertrampf E; Cortes F; Pardo A; Grosse SD; Uauy R
Health Policy; 2007 Oct; 83(2-3):295-303. PubMed ID: 17363103
[TBL] [Abstract][Full Text] [Related]
20. A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2022.
Wagh K; Kancherla V; Dorsey A; Pachón H; Oakley GP
Birth Defects Res; 2024 May; 116(5):e2343. PubMed ID: 38688860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
